| 注册
首页|期刊导航|中国药房|替吉奥联合艾迪注射液治疗晚期胃癌的Meta分析

替吉奥联合艾迪注射液治疗晚期胃癌的Meta分析

池志恒 虞舜 崔蒙

中国药房2017,Vol.28Issue(33):4675-4678,4.
中国药房2017,Vol.28Issue(33):4675-4678,4.DOI:10.6039/j.issn.1001-0408.2017.33.19

替吉奥联合艾迪注射液治疗晚期胃癌的Meta分析

Meta-analysis of Aidi Injection Combined with S-1 for Advanced Gastric Cancer

池志恒 1虞舜 1崔蒙1

作者信息

  • 1. 南京中医药大学中医药文献研究所/江苏省中医药防治肿瘤协同创新中心,南京210023
  • 折叠

摘要

Abstract

OBJECTIVE:To evaluate therapeutic efficacy and safety of Aidi injection combined with S-1 for advanced gastric cancer systematically,and to provide evidence-based reference. METHODS:Retrieved from CJFD,Wanfang database,VIP, CBM,Cochrane Library,PubMed and EMBase,randomized controlled trials(RCTs)about Aidi injection combined with S-1(tri-al group) vs. S-1 alone (control group) for advanced gastric cancer were collected. Meta-analysis was conducted by Rev Man 5.3 software after data extraction and quality evaluation by risk bias evaluation tool of Cochrane Handbook Version 5.1.0. RESULTS:A total of 8 RCT were included,involving 690 patients. Results of Meta-analysis showed that there was no statistical significance in therapeutic efficacy of solid tumor between 2 groups [OR=1.19,95%CI(0.88,1.61),P=0.26]. The improvement rate of survival quality[OR=3.62,95%CI(2.48,5.30),P<0.001],immunoglobulin level [CD3:SMD=1.31,95%CI(1.06,1.56),P<0.001;CD4:SMD=1.71,95%CI(1.38,2.04),P<0.001;CD8:SMD=-1.46,95%CI(-1.68,-1.23),P<0.001;CD4/CD8:SMD=1.45,95%CI(1.14,1.76),P<0.001] in trial group was significantly higher than control group. The incidence of leukopenia [RR=0.52,95%CI (0.40,0.68),P<0.001],thrombocytopenia [RR=0.49,95%CI(0.36,0.67),P<0.001] and gastrointestinal disorder [RR=0.56,95%CI(0.43,0.71),P<0.001] in trial group were significantly lower than control group,with statistical significance. CONCLUSIONS:Compared to S-1 alone,S-1 combined with Aidi injection can not significantly improve therapeutic efficacy of solid tumor therapy, but can improve survival quality and immunity of patients,as well as reduce the occurrence of ADR.

关键词

艾迪注射液/替吉奥/胃癌/Meta分析/疗效/副反应

Key words

Aidi injection/S-1/Gastric cancer/Meta-analysis/Therapeutic efficacy/Side reaction

分类

医药卫生

引用本文复制引用

池志恒,虞舜,崔蒙..替吉奥联合艾迪注射液治疗晚期胃癌的Meta分析[J].中国药房,2017,28(33):4675-4678,4.

基金项目

江苏高校协同创新中心课题(No.苏政办发〔2014)22号) (No.苏政办发〔2014)

江苏省优势学科建设工程项目(No.苏政办发〔2014)37号) (No.苏政办发〔2014)

中国药房

OA北大核心CSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文